10th Apr 2014 11:13
LONDON (Alliance News) - Oxford Biomedica PLC Thursday posted a widened pretax loss for 2013, as revenue wound down from its long-term collaboration with Sanofi S.A, although the company expressed confidence for 2014 as it looks to shift towards a more self-sustaining model. Oxford Biomedic Read More
